Lv5
1160 积分 2022-04-28 加入
QRL-201-01—A Multi-center, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of QRL-201 in Amyotrophic Lateral Sclerosis
1个月前
已关闭
Screening of a retinal-targeting Adeno-Associated Virus (AAV) via DNA shuffling
2个月前
已完结
King's 和 MiToS 分期系统预测肌萎缩侧索硬化疾病进展和生存能力的比较
4个月前
已完结
Tofersen: First Approval
4个月前
已完结
Prevalence of multiple system atrophy: A literature review
4个月前
已完结
Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment
4个月前
已完结
Multiple system atrophy: at the crossroads of cellular, molecular and genetic mechanisms
4个月前
已完结
Multiple system atrophy
5个月前
已完结
QRL-201-01—A Multi-center, Randomized, Double-blind, Placebo-controlled Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of QRL-201 in Amyotrophic Lateral Sclerosis (P6-11.010)
6个月前
已关闭
Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies
6个月前
已完结
皖公网安备34019202002308
